title: When "rare" is no excuse for progress.
authors.affiliation: Dana-Farber Cancer Institute, USA.
authors.forename: Donna
authors.initials: D
authors.lastname: Neuberg
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Arceci
mesh_terms: D005260:Female; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage*; D011241:Prednisone / Q000008:administration & dosage*; D014747:Vinblastine / Q000008:administration & dosage*
chemical_list: D007166:Immunosuppressive Agents; D014747:Vinblastine; D011241:Prednisone; D008727:Methotrexate